Plus Therapeutics Inc (NASDAQ:PSTV)’s traded shares stood at 2.48 million during the last session, with the company’s beta value hitting 0.64. At the close of trading, the stock’s price was $0.33, to imply a decrease of -5.69% or -$0.02 in intraday trading. The PSTV share’s 52-week high remains $2.33, putting it -606.06% down since that peak but still an impressive 27.27% since price per share fell to its 52-week low of $0.24.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
After registering a -5.69% downside in the last session, Plus Therapeutics Inc (PSTV) has traded red over the past five days. The 5-day price performance for the stock is -6.44%, and -48.59% over 30 days. With these gigs, the year-to-date price performance is -71.30%.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 46.51% for the past 5-year period. While 2025 is set for a 62.82% return in earnings, projections for the next 5 years are at 49.89% annually.
PSTV Dividends
Plus Therapeutics Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is GEODE CAPITAL MANAGEMENT, LLC with 46648.0 shares, or about 0.7176% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $68572.0.
